Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|April 10, 2008
A celecoxib derivative inhibits focal adhesion signaling and induces caspase-8-dependent apoptosis in human acute myeloid leukemia cellsIsolda Casanova, Rosa Bosch, Adriana Lasa, et al.
Disease Models & Mechanisms|February 4, 2014
Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer modelsPatricia Alamo, Alberto Gallardo, Miguel A Pavón, et al.
Cancers|January 8, 2023
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer ModelsEsperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, et al.
International Journal of Cancer|December 15, 2005
Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130CasIsolda Casanova, Matilde Parreño, Lourdes Farré, et al.
The American Journal of Pathology|September 4, 2010
Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer modelMaría Virtudes Céspedes, María Jesús Larriba, Miguel Angel Pavón, et al.
International Journal of Nanomedicine|August 28, 2012
Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticlesUgutz Unzueta, María Virtudes Céspedes, Neus Ferrer-Miralles, et al.
Carcinogenesis|May 9, 2006
K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12María Virtudes Céspedes, Francesc Josep Sancho, Silvia Guerrero, et al.
Acta Biomaterialia|September 9, 2019
Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4<sup>+</sup> colorectal cancerRita Sala, Laura Sánchez-García, Naroa Serna, et al.
Pharmaceutics|January 21, 2022
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid MaterialsNaroa Serna, Aïda Falgàs, Annabel García-León, et al.
Acta Biomaterialia|September 8, 2023
High-precision targeting and destruction of cancer-associated PDGFR-β<sup>+</sup> stromal fibroblasts through self-assembling, protein-only nanoparticlesEric Voltà-Durán, Lorena Alba-Castellón, Naroa Serna, et al.
Pageof 7